Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1065 of 6351
-
Scarless procedure may keep precancerous esophagus changes from returning
Disease control By invitation onlyBarrett's esophagus (BE) is a precancerous lesion characterized by the replacement of the normal stratified squamous epithelium of the distal esophagus by intestinal metaplasia (IM). Non-dysplastic BE may progress to low-grade dysplasia (LGD), to high-grade dysplasia (HGD) and es…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Poop pills? fecal transplants show promise for gut infections
Disease control CompletedThe study will provide data to show the effectiveness of Fecal Microbiota Transplant in patients with recurrent Clostridium difficile infection. Fecal Microbiota Transplant (FMT) is a procedure in which healthy colon contents of a carefully screened donor is inserted into the co…
Phase 4 • Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a High-Tech radiation beam hit prostate tumors without harming healthy tissue?
Disease control OngoingThe purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minim…
Sponsor: Linda Chan, MD • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for kids with tough cancers: targeted drug shows promise in Gene-Matched tumors
Disease control OngoingThis phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with FGFR mutations that have spread to other places in the body and have come back or do not respond to treatment. Erdafi…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy offers hope for melanoma patients who failed standard treatment
Disease control OngoingThis phase II trial studies how well talimogene laherparepvec and pembrolizumab work in treating patients with stage III-IV melanoma. Biological therapies, such as talimogene laherparepvec, use substances made from living organisms that may stimulate or suppress the immune system…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could antibody infusions replace daily HIV pills?
Disease control CompletedThe proposed study is a phase 1, open label, randomized study to evaluate the safety and antiretroviral activity of seven infusions of 3BNC117 and 10-1074, administered intravenously at 30 mg/kg dose level, in human immunodeficiency virus (HIV)-infected individuals on combination…
Phase 1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Gene Therapy's lasting effects on vision tracked in Long-Term study
Disease control CompletedThe objective of the study is to evaluate the long-term safety and efficacy of a sub-retinal injection of BIIB111 in participants with Choroideremia (CHM) who have been previously treated with BIIB111 and who have exited an antecedent study; these treated participants will be com…
Phase 3 • Sponsor: NightstaRx Ltd, a Biogen Company • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a common arthritis drug tame the painful Flare-Ups of leprosy?
Disease control CompletedErythema nodosum leprosum (ENL) is characterized by painful nodules and systemic compromising. It is usually recurrent and/or chronic and has both physical and economic impact on the patient, being a very important cause of morbidity and mortality. In addition, ENL is a major hea…
Phase 1 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Mind over muscles: brain chip lets paralyzed man grasp objects
Disease control CompletedThis study is for people who have a paralyzed arm and hand from a spinal cord injury, who have also received a recording electrode array in the brain as part of the BrainGate study. The study will look at the ability of these participants to control different grasping patterns of…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart attack prevention: does opening a blocked artery save lives?
Disease control OngoingRandomized registry for the study of CTO PCI as adjunction to optimal medical therapy.
Sponsor: Leif Thuesen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo therapy shows promise for tough liver cancer cases
Disease control CompletedImmune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma with vascular invasions
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a triple therapy beat back tough liver cancer?
Disease control CompletedAnti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors (VEGF/TKI-ICI) plus Immune checkpoint inhibitors (ICIs) are recommended for patients with unresectable hepatocellular carcinoma (HCC) with PVTT in China. However, these treatments have limited survival be…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo approach before surgery may improve outcomes for massive liver tumors
Disease control CompletedThis retrospective cohort study collected data of patients with huge hepatocellular carcinoma (HCC) treated between June 1, 2018, and December 31, 2023, through the hospital information system. Patients were divided into a neoadjuvant conversion-first cohort and an upfront surger…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
MRI tracer could expose hidden brain energy crisis after head injury
Diagnosis By invitation onlyThis project is to evaluate sensitivity and specificity of hyperpolarized 13C-pyruvate as imaging agents of altered cerebral glycolysis and mitochondrial dysfunction and assess pyruvate utilization in mitochondria in Traumatic Brain Injury (TBI) patients.
Early phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy offers hope for older leukemia patients
Disease control CompletedThe trial proposed here attempts to reduce induction chemotherapy to phase I of standard induction in patients with B-precursor ALL. Induction phase II will be replaced by blinatumomab. The initial treatment phase is followed by sequential chemotherapy and further blinatumomab c…
Phase 2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Implanted electrical system aims to restore movement in paralyzed limbs
Disease control Recruiting nowThe purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate exercise, standing, stepping and/or balance in people with various degrees of paralysis.
Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Keyhole surgery for ankle instability: a less invasive fix?
Disease control CompletedThis study mainly evaluated the clinical effect of total arthroscopic repair of the anterior talofibular ligament in the treatment of chronic instability of the lateral ankle. For patients with chronic instability of the lateral ankle, a randomized controlled trial was used to co…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Digital nudge: can text messages keep latinas active for the long haul?
Prevention CompletedThis renewal builds upon our successful culturally adapted PA intervention for Latinas (Pasos Hacia La Salud, R01CA159954) and expands its focus to the critical area of maintenance of behavior change. This study will test an enhanced version of the original internet intervention …
Sponsor: Brown University • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy targets aggressive brain cancer
Disease control OngoingPhase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma (GBM).
Phase 1/2 • Sponsor: Inovio Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Immunotherapy combo shows promise in Hard-to-Treat colorectal cancer
Disease control CompletedThis study aims to determine the efficacy, safety, and tolerability of the sequential addition of immune-modulating therapy to standard-of-care therapy of microsatellite-stable (MSS)/mismatch repair-proficient (pMMR) metastatic colorectal cancer (mCRC).
Phase 2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC